logo-loader
viewThe Flowr Corporation

Flowr finalizes deal with Holigen

The firm announced Tuesday it has completed the acquisition of the remaining 80.2% interest in Holigen Holdings through a share purchase agreement

The Flowr Corporation - Flowr finalizes deal with Holigen
The Toronto-based company builds and operates large-scale, GMP-designed facilities that utilize proprietary growing methods to produce high-quality cannabis for recreational and medicinal usage

The Flowr Corporation (CVE:FLWR) (OTCMKTS:FLWPF) announced Tuesday it has completed the acquisition of the remaining 80.2% interest in Holigen Holdings through a share purchase agreement. 

The Toronto-based company builds and operates large-scale, GMP-designed facilities that utilize proprietary growing methods to produce high-quality cannabis for recreational and medicinal usage.

READ: Flowr Corp ramps up production and pushes flagship Kelowna campus forward in 2Q

"We are excited to complete the acquisition of Holigen and thereby add operations in Portugal and Australia to our existing Canadian platform. The combination of our extensive cannabis cultivation know-how and Holigen's extensive pharmaceutical experience has the potential to create tremendous value. With an expected annual capacity of 500,000 kilograms, the Aljustrel cultivation asset in Portugal should allow us to be a significant producer in the global medical cannabis and active pharmaceutical ingredient (API) markets, initially in Europe and Australia-Asia," said Vinay Tolia, Flowr's CEO.

Flowr’s flagship Kelowna production facility, currently under development, is expected to produce over 50,000-square kilograms of premium flower annually once fully operational.

"We continue to see the cannabis market bifurcating into premium, superior quality adult-use products, where legal, and a global medical opportunity that will require massive production scale and deep GMP expertise. With the completion of this acquisition, the subsequent ramp-up of production at Aljustrel, and the continued buildout of our campus in Kelowna, Flowr is strategically positioned to service the global cannabis market from an efficient footprint."

The firm noted a number of terms for the acquisition, which included cash consideration of C$6.3 million, issuance of 32.6 million shares, with 10% of the consideration shares converting into common shares after closing and 40% of the consideration share converting into common shares six month from the closing. 

The firm noted 40% of the consideration shares will automatically convert into common shares. The remaining 50% of the consideration shares will convert into common shares when and if Holigen achieves certain milestones related to the lodging of product applications and achieving certain planting targets in Australia and Portugal. 

Shares of Flowr were up 5% at C$2.95 in Toronto. 

Contact Katie Lewis at [email protected]

Quick facts: The Flowr Corporation

Price: 2.1 CAD

TSX-V:FLWR
Market: TSX-V
Market Cap: $224.66 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of The Flowr Corporation named herein, including the promotion by the Company of The Flowr Corporation in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

The Flowr Corporation talks planned scale up of cannabis cultivation...

The Flowr Corporation (CVE:FLWR) (OTCMKTS:FLWPF) Head of Capital Markets Thierry Elmaleh sat down with Proactive at the Cannabis Europa: Transatlantic Forum in Toronto.  Elmaleh talked about how Flow plans to scale up its subsidiary Holigen, which has a license for cannabis cultivation...

on 6/11/19

2 min read